NCT01383759 · OUTCOME

Organ Response - Renal Involvement at 12 Months

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis · Source last updated 2020-04-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: 12 months

What was measured

12 months post-initiation of treatment following the 3 phase comprehensive treatment approach including induction with BD, followed by risk adapted HDM/ASCT, followed by consolidation/maintenance therapy with BD in patients with AL amyloidosis.

Groups in this outcome

Amyloidosis

Participants with newly diagnosed AL amyloidosis

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Amyloidosis	19

Reported measurements

Source class 1

No renal involvment

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Amyloidosis	7	Not reported	Not reported	Not reported	Not reported

Renal involvment, improved

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Amyloidosis	9	Not reported	Not reported	Not reported	Not reported

Renal involvment, profressed

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Amyloidosis	2	Not reported	Not reported	Not reported	Not reported

Renal involvment, died

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Amyloidosis	1	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
7
title
No renal involvment
measurements
group Id
OG000
value
9
title
Renal involvment, improved
measurements
group Id
OG000
value
2
title
Renal involvment, profressed
measurements
group Id
OG000
value
1
title
Renal involvment, died

denoms

counts
group Id
OG000
value
19
units
Participants

description

groups

description
Participants with newly diagnosed AL amyloidosis
id
OG000
title
Amyloidosis

param Type

COUNT_OF_PARTICIPANTS

reporting Status

POSTED

time Frame

12 months

title

Organ Response - Renal Involvement at 12 Months

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice